Saturday, July 11, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “REGENESANCE B.V.”

6 pharma patents match "REGENESANCE B.V." in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 6
Index total 30,257
Page 1 / 1

Quick answer

This filtered view shows 6 pharmaceutical patents matching "REGENESANCE B.V." in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

6 results for “REGENESANCE B.V.” · 30,257 patents in full index Clear search

  1. US 12194091

    Antibodies that bind human C6 and uses thereof

    REGENESANCE B.V. · Granted Jan 14, 2025 · Expires Jan 9, 2045

    granted

  2. US 11590222

    Antibodies that bind human C6 and uses thereof

    REGENESANCE B.V. · Granted Feb 28, 2023 · Expires Feb 23, 2043

    granted

  3. US 10675348

    Antibodies that bind human C6 and uses thereof

    REGENESANCE B.V. · Granted Jun 9, 2020 · Expires Jun 4, 2040

    granted

  4. US 9089555

    Complement antagonists and uses thereof

    REGENESANCE B.V. · Granted Jul 28, 2015 · Expires Jul 23, 2035

    granted

  5. US 8703730

    Complement antagonists and uses thereof

    REGENESANCE B.V. · Granted Apr 22, 2014 · Expires Apr 17, 2034

    granted

  6. US 8703136

    Complement inhibition for improved nerve regeneration

    REGENESANCE B.V. · Granted Apr 22, 2014 · Expires Apr 17, 2034

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.